Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
ResMed Inc.’s CEO Michael J. Farrell has engaged in a significant stock transaction, acquiring 14,683 shares at $84.98 each and selling the same number at a weighted average price of $231.91. The transactions, executed on October 7, 2024, were part of a pre-arranged Rule 10b5-1 trading plan adopted at the start of the year. Following these transactions, Farrell’s direct holdings in the company adjusted to 464,169 shares.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
